Login to Your Account



PregLem In-Licenses Merck Serona's Jun Kinase Inhibitor

By Cormac Sheridan


Wednesday, August 18, 2010
PregLem SA is in-licensing an oral, preclinical Jun kinase inhibitor, bentamapimod (AS602801), from Merck Serono SA, for prevention of postsurgical abdominal adhesions and endometriosis in patients. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription